Legal Representation
Attorney
Mainak H. Mehta
USPTO Deadlines
Next Deadline
455 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-10-11)
Due Date
October 11, 2026
Grace Period Ends
April 11, 2027
Application History
38 eventsDate | Code | Type | Description |
---|---|---|---|
Nov 23, 2024 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
Nov 23, 2024 | C75A | O | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. |
Oct 23, 2023 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
Jul 11, 2023 | PR75 | O | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 |
Mar 24, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Jan 13, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Sep 26, 2022 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED |
Oct 11, 2021 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Dec 14, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Dec 14, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Mar 10, 2017 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
Feb 16, 2017 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Feb 16, 2017 | FIMP | P | FINAL DISPOSITION PROCESSED |
Jan 11, 2017 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Oct 12, 2016 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Oct 11, 2016 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jul 26, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jul 26, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 6, 2016 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Jul 6, 2016 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Jul 6, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 17, 2016 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 16, 2016 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Jun 16, 2016 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Jun 16, 2016 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
Jun 16, 2016 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Jun 14, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jun 14, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
May 14, 2016 | RFNT | P | REFUSAL PROCESSED BY IB |
Apr 22, 2016 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Apr 21, 2016 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Apr 21, 2016 | RFRR | P | REFUSAL PROCESSED BY MPU |
Apr 21, 2016 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Apr 20, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 18, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
Apr 18, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Apr 15, 2016 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
Apr 7, 2016 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Specialized excipient mixture without the pharmaceutical ingredient, used in the manufacture of rapidly disintegrating pharmaceutical tablets; chemical additives for use in the manufacture of food; chemical food additives for use in the manufacture of supplements; chemical food additives for use in the manufacture of nutritional supplements; chemicals, namely, disintegrating modifiers for use in the field of coating materials; excipients for use in the manufacture of pharmaceutical preparations and supplements; chemical agents for manufacturing supplements; chemicals used in industry and science; chemical preparations for use in the manufacture of pharmaceuticals, namely, raw materials and auxiliaries for the direct compression manufacturing of rapidly disintegrating tablets
Class 005
Delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of nutritional supplements; dietary and nutritional supplements; dietary food supplements; dietary and nutritional supplements containing cellulose; cellulose ethers for pharmaceutical purposes; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; health food supplements; medicinal preparations for the mouth to be applied in the form of films, capsules, tablets and compressed tablets; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the rapidly disintegrating of a wide variety of therapeutic agents
Additional Information
Translation
The wording "DISPERZISTA" has no meaning in a foreign language.
Classification
International Classes
001
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO